Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

Abstract Autologous hematopoietic stem cell transplantation (AHSCT) has been used in the treatment of highly active multiple sclerosis (MS) for over two decades. It has been demonstrated to be highly efficacious in relapsing–remitting (RR) MS patients failing to respond to disease-modifying drugs (D...

Full description

Bibliographic Details
Main Authors: Antonio Bertolotto, Serena Martire, Luca Mirabile, Marco Capobianco, Marco De Gobbi, Daniela Cilloni
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-06-01
Series:Neurology and Therapy
Subjects:
ASBMT
Autologous hematopoietic stem cell transplantation
Clinical option
Costs
EBMT-ADWP
Guidelines
Online Access:https://doi.org/10.1007/s40120-020-00200-9

Internet

https://doi.org/10.1007/s40120-020-00200-9

Similar Items